M L23 (Lisinopril 5 mg)
Pill with imprint M L23 is Orange, Round and has been identified as Lisinopril 5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; alport syndrome; coronary artery disease (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for M L23
- M L23
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
sodium lauryl sulfate
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|51079-0981||UDL Laboratories Inc.|
|63874-0558||Altura Pharmaceuticals Inc. (repackager)|
More about lisinopril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 446 Reviews – Add your own review/rating
- Drug class: Angiotensin Converting Enzyme Inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.